tiprankstipranks
Altimmune Inc (ALT)
NASDAQ:ALT

Compare Altimmune (ALT) vs. Competitors

Compare
3,622 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Altimmune
$3.02
$392.81M
-3.61
-45.78%
5 Buy
1 Hold
0 Sell
Strong Buy
Tvardi Therapeutics
$3.17
$29.74M
-16.53
-80.36%
2 Buy
0 Hold
0 Sell
Moderate Buy
Diamedica Therapeutics
$6.79
$353.61M
-9.89
64.01%
3 Buy
0 Hold
0 Sell
Strong Buy
Alpha Tau Medical Ltd
$6.84
$603.75M
157.89%
2 Buy
1 Hold
0 Sell
Moderate Buy
enGene Holdings
$6.37
$426.72M
-5.39
34.11%
6 Buy
1 Hold
0 Sell
Strong Buy
Lexeo Therapeutics, Inc.
$5.46
$398.51M
-4.99
32.85%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ALT
Altimmune
3.02
-2.30
-43.23%
TVRD
Tvardi Therapeutics
3.17
-12.28
-79.48%
DMAC
Diamedica Therapeutics
6.79
2.97
77.75%
DRTS
Alpha Tau Medical Ltd
6.86
4.30
167.97%
ENGN
enGene Holdings
6.37
2.07
48.14%
LXEO
Lexeo Therapeutics, Inc.
5.46
1.36
33.17%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts